Literature DB >> 12216076

Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients.

Young-Woon Chang1, Yo-Seob Han, Dong-Keun Lee, Hyo-Jong Kim, Hyun-Seok Lim, Jeong-Seop Moon, Seok-Ho Dong, Byung-Ho Kim, Joung-Il Lee, Rin Chang.   

Abstract

A positive family history is an increased risk factor for gastric cancer within family members, and one of the possible causes of this is the intrafamilial clustering of Helicobacter pylori infection. Our study examined the prevalence of H. pylori infection, serum antibodies to CagA and VacA and atrophic gastritis and/or intestinal metaplasia in the offspring or siblings of gastric cancer patients. A total of 726 subjects included 300 relatives of 300 separate gastric cancer patients and 426 controls. All subjects underwent upper gastrointestinal endoscopic examination with a rapid urease test. Blood samples were obtained to test for the presence of serum antibodies to the CagA and VacA proteins of H. pylori. The prevalence of H. pylori infection was higher in relatives of cancer patients (75.3%) than in controls (60.1%), and the adjusted odds ratio was 2.1 (95% CI 1.5-2.9). When either siblings or 2 or more family members were gastric cancer patients, the prevalence of H. pylori infection was much higher compared to the prevalence in controls. There was no specific relationship between CagA and VacA, and H. pylori infection. Atrophic gastritis and/or intestinal metaplasia were more frequently found in H. pylori-infected relatives of cancer patients (26.1%) than in H. pylori-infected controls (12.9%). These results strongly support a role for H. pylori infection in familial aggregation of gastric cancer. The prophylactic eradication of H. pylori infection in the offspring or siblings of gastric cancer patients may be clinically beneficial. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12216076     DOI: 10.1002/ijc.10637

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Family history is an independent risk factor for the progression of gastric atrophy among patients with Helicobacter pylori infection.

Authors:  Toshihiro Nishizawa; Hidekazu Suzuki; Kosuke Sakitani; Hiroharu Yamashita; Shuntaro Yoshida; Keisuke Hata; Takamitsu Kanazawa; Naoto Fujiwara; Takanori Kanai; Naohisa Yahagi; Osamu Toyoshima
Journal:  United European Gastroenterol J       Date:  2016-06-22       Impact factor: 4.623

2.  First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies?

Authors:  Ricardo Marcos-Pinto; Mário Dinis-Ribeiro; Fátima Carneiro; José Carlos Machado; Ceu Figueiredo; Celso A Reis; José Ferreira; Jorge Areias
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

3.  Helicobacter pylori Seropositivity Is Associated with Gastric Cancer Regardless of Tumor Subtype in Korea.

Authors:  Soo-Jeong Cho; Il Ju Choi; Chan Gyoo Kim; Jong Yeul Lee; Myeong-Cherl Kook; Moon-Woo Seong; Sook Ryun Park; Jong Seok Lee; Young-Woo Kim; Keun Won Ryu; Jun Ho Lee; Byung-Ho Nam; Young-Iee Park
Journal:  Gut Liver       Date:  2010-12-17       Impact factor: 4.519

4.  Follow-up of intestinal metaplasia in the stomach: When, how and why.

Authors:  Angelo Zullo; Cesare Hassan; Adriana Romiti; Michela Giusto; Carmine Guerriero; Roberto Lorenzetti; Salvatore Ma Campo; Silverio Tomao
Journal:  World J Gastrointest Oncol       Date:  2012-03-15

Review 5.  Current progress toward eradicating Helicobacter pylori in East Asian countries: differences in the 2013 revised guidelines between China, Japan, and South Korea.

Authors:  Sun-Young Lee
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

6.  Helicobacter pylori infection, but not genetic polymorphism of CYP2E1, is highly prevalent in gastric cancer patients younger than 40 years.

Authors:  Gotaro Masuda; Akira Tokunaga; Takashi Shirakawa; Akiyoshi Togashi; Teruo Kiyama; Shunji Kato; Norio Matsukura; Hideki Bou; Masanori Watanabe; Takashi Tajiri
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

7.  MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer.

Authors:  Valli De Re; R Cannizzaro; V Canzonieri; E Cecchin; L Caggiari; E De Mattia; C Pratesi; P De Paoli; G Toffoli
Journal:  Tumour Biol       Date:  2009-12-18

8.  Higher frequency of cagA EPIYA-C phosphorylation sites in H. pylori strains from first-degree relatives of gastric cancer patients.

Authors:  Dulciene M M Queiroz; Cícero I S M Silva; Maria H R B Goncalves; Manuel B Braga-Neto; Andréa B C Fialho; André M N Fialho; Gifone A Rocha; Andreia M C Rocha; Sérgio A Batista; Richard L Guerrant; Aldo A M Lima; Lucia L B C Braga
Journal:  BMC Gastroenterol       Date:  2012-08-14       Impact factor: 3.067

9.  Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer.

Authors:  Jeongseon Kim; Young Ae Cho; Il Ju Choi; Yeon-Su Lee; Sook-Young Kim; Aesun Shin; Soo-Jeong Cho; Myeong-Cherl Kook; Ji Hyung Nam; Keun Won Ryu; Jun Ho Lee; Young-Woo Kim
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

10.  Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea.

Authors:  Young-Eun Joo; Hyun-Kyung Park; Dae-Seong Myung; Gwang-Ho Baik; Jeong-Eun Shin; Geom-Seog Seo; Gwang Ha Kim; Heung Up Kim; Hyun Young Kim; Sung-Il Cho; Nayoung Kim
Journal:  Gut Liver       Date:  2013-05-13       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.